English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 911433      線上人數 : 907
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版

    子類別

    圖書 [5/7]
    會議論文/會議摘要 [25/32]
    期刊論文 [158/158]

    鄰近社群


    MARK LAWRENCE WAHLQVIST(2008-2012) [138/140]
    吳易謙 [54/55]
    吳秀英 [10/10]
    廖本揚 [39/39]
    廖玉潔 [63/65]
    張新儀 [245/268]
    李孟智 [51/54]
    李蘭 [28/28]
    林培生 [25/25]
    林煜軒 [47/47]
    林肇堂 [35/35]
    梁賡義 [15/15]
    江博煌 [72/78]
    溫啟邦(2001-2010) [177/188]
    潘文涵 [110/115]
    熊昭 [369/379]
    莊淑鈞 [43/44]
    莊紹源 [162/168]
    蔡慧如 [162/165]
    蔡憶文(1999-2010) [34/34]
    藍祚運(2003-2011) [22/23]
    許志成 [385/393]
    邱亞文(2005-2013) [63/99]
    邱弘毅 [49/49]
    邱燕楓 [82/82]
    郭耿南(2003-2010) [89/105]
    鄒小蕙 [101/105]
    鍾仁華 [85/86]
    陳主智 [61/61]
    陳慶餘(2006-2010) [70/70]
    陳美惠 [32/32]
    陳豐奇 [53/55]
    陳麗光 [106/106]
    黃國晉 [15/15]
    丘政民(2000-2004) [8/8]
    其他 [238/244]
    劉仁沛(1998-2002) [64/65]
    姚姿君(1999-2002) [3/3]
    戴東原(2003-2005) [21/22]
    李明亮(2003-2007) [6/6]
    林仲彥(1999-2005) [31/33]
    林錦瑜(2002-2003) [5/5]
    涂醒哲(2003-2004) [4/4]
    石曜堂(1999-2006) [20/24]
    蔡碧紋(2004-2006) [3/4]
    陳淑媛(2001-2004) [3/3]

    社群統計


    近3年內發表的文件:19(9.64%)
    含全文筆數:188(95.43%)

    文件下載次數統計
    下載大於0次:188(100.00%)
    下載大於100次:177(94.15%)
    檔案下載總次數:95304(1.78%)

    最後更新時間: 2024-12-01 03:20

    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目51-75 / 197. (共8頁)
    << < 1 2 3 4 5 6 7 8 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2017-07 Exposure sources and their relative contributions to urinary phthalate metabolites among children in Taiwan International Journal of Hygiene and Environmental Health. 2017 Jul;220(5):869-879.
    2017-06-30 Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints PLoS ONE. 2017 Jun 30;12(6):Article number e0180405.
    2017-05 Efficient group-sequential designs for monitoring two time-to-event outcomes in clinical trials Trials. 2017 May;18(Suppl. 1):Meeting Abstract P36.
    2017-03 Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line TKIs American Journal of Respiratory and Critical Care Medicine. 2017 Mar;195(5):663-673.
    2017-03 An approach for sample size determination of average bioequivalence based on interval estimation Statistics in Medicine. 2017 Mar;36(7):1068-1082.
    2017-02 Integrated care for geriatric frailty and sarcopenia: A randomized control trial Journal of Cachexia, Sarcopenia and Muscle. 2017 Feb;8(1):78-88.
    2017-01 Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations Human Molecular Genetics. 2017 Jan;26(2):454-465.
    2016-11-11 Assessing benefit and consistency of treatment effect under a discrete random effects model in multiregional clinical trials Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics. 2016 Nov 11:127-136.
    2016-10 The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study Annals of Oncology. 2016 Oct;27(Suppl.6 ):Meeting Abstract 973P.
    2016-06 Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials Statistics in Medicine. 2016 Jun;35(14):2301-2314.
    2016-04-21 The discrete random-effects model-assessing benefit and consistency of treatment effect Multiregional Clinical Trials for Simultaneous Global New Drug Development. 2016 Apr 21:245-258.
    2016-01-04 Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women Human Molecular Genetics. 2016 Jan 4;25(3):620-629.
    2016-01 A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial Medicine. 2016 Jan;95(3):Article number e2565.
    2015-12 Analysis of heritability and shared heritability based on genome-wide association studies for 13 cancer types Journal of the National Cancer Institute. 2015 Dec;107(12):Article number djv279.
    2015-12 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99.
    2015-10 Quality of life changes in patients undergoing treatment for hepatocellular carcinoma Quality of Life Research. 2015 Oct;24(10):2499-2506.
    2015-10 Estrogen receptor gene polymorphisms and lung adenocarcinoma risk in never-smoking women Journal of Thoracic Oncology. 2015 Oct;10(10):1413-1420.
    2015-09-01 Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients International Journal of Cardiology. 2015 Sep 1;194:36-38.
    2015-07 Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia International Journal of Cancer. 2015 Jul;137(2):311-319.
    2015-05 Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4101.
    2015-05 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024.
    2015-03 Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA) Human Genetics. 2015 Mar;134(3):333-341.
    2014-12 Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 Human Molecular Genetics. 2014 Dec;23(24):6616-6633.
    2014-10-13 Sample size determination for individual bioequivalence inference PLoS ONE. 2014 Oct 13;9(10):Article number e109746.
    2014-10 Use of a bayesian approach to design and evaluation of NCE2 Pharmacoepidemiology and Drug Safety. 2014 Oct;23(S1):432.

    顯示項目51-75 / 197. (共8頁)
    << < 1 2 3 4 5 6 7 8 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋